- Report
- July 2023
- 186 Pages
Global
From €3483EUR$3,554USD£3,030GBP
€3870EUR$3,949USD£3,366GBP
- Report
- July 2023
- 184 Pages
Global
From €3483EUR$3,554USD£3,030GBP
€3870EUR$3,949USD£3,366GBP
- Report
- September 2023
- 175 Pages
Global
From €4900EUR$5,000USD£4,262GBP
- Report
- June 2023
- 275 Pages
Global
From €4900EUR$5,000USD£4,262GBP
- Report
- February 2023
- 175 Pages
Global
From €4900EUR$5,000USD£4,262GBP
- Report
- September 2023
- 193 Pages
Global
From €4851EUR$4,950USD£4,219GBP
- Report
- September 2023
- 194 Pages
Global
From €4851EUR$4,950USD£4,219GBP
- Report
- July 2023
- 146 Pages
Global
From €2449EUR$2,499USD£2,130GBP
- Report
- January 2023
- 213 Pages
Global
From €3528EUR$3,600USD£3,069GBP
- Report
- January 2023
- 196 Pages
Global
From €3528EUR$3,600USD£3,069GBP
- Report
- April 2023
- 115 Pages
Global
From €4189EUR$4,275USD£3,644GBP
€4655EUR$4,750USD£4,049GBP
- Report
- June 2023
- 200 Pages
Global
From €7350EUR$7,500USD£6,393GBP
- Clinical Trials
- May 2023
- 250 Pages
Global
From €2940EUR$3,000USD£2,557GBP
- Report
- April 2023
- 240 Pages
Global
From €3430EUR$3,500USD£2,983GBP
- Report
- November 2022
- 213 Pages
Global
From €5679EUR$5,795USD£4,940GBP
- Report
- November 2022
- 120 Pages
Global
From €2450EUR$2,500USD£2,131GBP
- Report
- July 2023
- 229 Pages
Global
From €4410EUR$4,500USD£3,836GBP
- Report
- November 2022
- 100 Pages
Global
From €2695EUR$2,750USD£2,344GBP
- Report
- November 2022
- 210 Pages
Global
From €5615EUR$5,730USD£4,884GBP
- Report
- April 2023
- 110 Pages
Global
From €4189EUR$4,275USD£3,644GBP
€4655EUR$4,750USD£4,049GBP

The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more